Insider Transactions
Date | Filer | Filing | Type | Shares Traded | Total Held |
---|---|---|---|---|---|
Jul 06, 2020 |
Director
Trans History: 111
|
Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 101,729 | 152,227 |
Jul 06, 2020 |
Director
Trans History: 123
|
Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 101,729 | 152,247 |
Jul 06, 2020 |
VP - Controller & PAO
Trans History: 11
|
Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 298,407 | 334,157 |
Jul 06, 2020 |
Director
Trans History: 113
|
Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 101,729 | 289,397 |
Jul 06, 2020 |
President, COO & CTO
Trans History: 264
|
Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 454,393 | 627,002 |
Jul 06, 2020 |
Chief Financial Officer
Trans History: 10
|
Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 406,919 | 531,055 |
Jul 06, 2020 |
General Counsel & Secretary
Trans History: 14
|
Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 264,497 | 380,255 |
Jul 01, 2020 |
Chief Commercial Officer
Trans History: 15
|
Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 11,284 | 200,761 |
Jul 01, 2020 |
Director, Chief Executive Officer
Trans History: 212
|
Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 17,361 | 460,980 |
Jul 01, 2020 |
VP - Controller & PAO
Trans History: 11
|
Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 7,638 | 35,750 |
* Represents the number of non-derivative securities directly held. (I) Indicates that some (or all) of these shares are held indirectly.